Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model
暂无分享,去创建一个
[1] Runping Liu,et al. Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes , 2020, PloS one.
[2] Haowen Jiang,et al. Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans , 2019, Cell Death & Disease.
[3] H. Hosseinzadeh,et al. Berberine and barberry (Berberis vulgaris): A clinical review , 2019, Phytotherapy research : PTR.
[4] Runsen Chen,et al. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway , 2019, Current Medical Science.
[5] Runsen Chen,et al. Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2/ARE signalling pathway , 2019, Experimental and therapeutic medicine.
[6] S. Zang,et al. Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice. , 2019, American journal of translational research.
[7] Jian-Dong Jiang,et al. Syntaxin 1B Mediates Berberine’s Roles in Epilepsy-Like Behavior in a Pentylenetetrazole-Induced Seizure Zebrafish Model , 2018, Front. Mol. Neurosci..
[8] Tingting Hu,et al. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] J. Friedman,et al. Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease , 2018, The Journal of clinical investigation.
[10] V. Nobili,et al. Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future? , 2018, Expert review of gastroenterology & hepatology.
[11] Bo Chen,et al. Comparative Study of Different Diets-Induced NAFLD Models of Zebrafish , 2018, Front. Endocrinol..
[12] Changqin Hu,et al. Cardiac safety evaluation in zebrafish and in silico ADME prediction of cephalosporins with an aminothiazoyl ring at the C‐7 position , 2018, Toxicology and applied pharmacology.
[13] Yiming Yu,et al. shinyCircos: an R/Shiny application for interactive creation of Circos plot , 2018, Bioinform..
[14] Xin Gao,et al. Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21 , 2018, British journal of pharmacology.
[15] Hongyang Wang,et al. Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis , 2017, Science China Life Sciences.
[16] M. Jenmalm. The mother–offspring dyad: microbial transmission, immune interactions and allergy development , 2017, Journal of internal medicine.
[17] V. Alla,et al. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis. , 2017, Diabetes & metabolic syndrome.
[18] Filippo Del Bene,et al. CRISPR/Cas9-Mediated Knockin and Knockout in Zebrafish , 2017 .
[19] Jingfeng Liu,et al. Circulating tumor DNA profiling reveals clonal evolution and real‐time disease progression in advanced hepatocellular carcinoma , 2017, International journal of cancer.
[20] Y. Liu,et al. Embryo and Developmental Toxicity of Cefazolin Sodium Impurities in Zebrafish , 2017, Front. Pharmacol..
[21] C. Alves,et al. Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update , 2017, Nutricion hospitalaria.
[22] P. So,et al. Development of a classification model for non‐alcoholic steatohepatitis (NASH) using confocal Raman micro‐spectroscopy , 2017, Journal of Biophotonics.
[23] E. Levy,et al. Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis. , 2017, Antioxidants & redox signaling.
[24] Yingli Lu,et al. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease , 2017, BMC Endocrine Disorders.
[25] M. Raponi,et al. Clinical implications of understanding the association between oxidative stress and pediatric NAFLD , 2017, Expert review of gastroenterology & hepatology.
[26] Chung S. Yang,et al. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway , 2017, Molecular Pharmacology.
[27] J. Adjaye,et al. Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease , 2016, Stem cells.
[28] Clinical Implications. , 2017, Hypertension.
[29] B. Neuschwander‐Tetri,et al. In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores. , 2016, Gastroenterology.
[30] Xin Gao,et al. The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease , 2016, Molecules.
[31] A. Feldstein,et al. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. , 2016, Metabolism: clinical and experimental.
[32] Sjoerd Stallinga,et al. Deconvolution methods for structured illumination microscopy. , 2016, Journal of the Optical Society of America. A, Optics, image science, and vision.
[33] T. Kietzmann,et al. Reactive oxygen species and fibrosis: further evidence of a significant liaison , 2016, Cell and Tissue Research.
[34] E. Elinav,et al. Non-alcoholic fatty liver and the gut microbiota , 2016, Molecular metabolism.
[35] A. Alisi,et al. Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease. , 2016, Gastroenterology.
[36] Zheng-Xiao Zhao,et al. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress. , 2016, Biochemical and biophysical research communications.
[37] R. A. Forse,et al. Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children , 2016, Obesity Surgery.
[38] Yinshi Sun,et al. Preparative Isolation of Two Prenylated Biflavonoids from the Roots and Rhizomes of Sinopodophyllum emodi by Sephadex LH-20 Column and High-Speed Counter-Current Chromatography , 2015, Molecules.
[39] Yiyue Zhang,et al. High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs , 2015, Nutrition & Metabolism.
[40] Haishan Zeng,et al. Accurate assessment of liver steatosis in animal models using a high throughput Raman fiber optic probe. , 2015, The Analyst.
[41] W. Jia,et al. Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease , 2015, PloS one.
[42] D. Weghuber,et al. The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease , 2015, BioMed research international.
[43] Mary E Rinella,et al. Nonalcoholic fatty liver disease: a systematic review. , 2015, JAMA.
[44] Jinrong Peng,et al. Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting , 2014, Hepatology.
[45] R. Matthews,et al. Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibition , 2014, Hepatology.
[46] G. Paradies,et al. Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. , 2014, World journal of gastroenterology.
[47] K. Kochan,et al. Raman imaging providing insights into chemical composition of lipid droplets of different size and origin: in hepatocytes and endothelium. , 2014, Analytical chemistry.
[48] Nicolas C Pégard,et al. Three-dimensional deconvolution microfluidic microscopy using a tilted channel , 2013, Journal of biomedical optics.
[49] Miriam B. Vos,et al. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. , 2013, The Journal of pediatrics.
[50] M. Rämet,et al. The zebrafish as a model for paediatric diseases , 2013, Acta paediatrica.
[51] Amnon Schlegel. Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiology , 2012, Cellular and Molecular Life Sciences.
[52] F. Marlow,et al. Mutations in vacuolar H+ -ATPase subunits lead to biliary developmental defects in zebrafish. , 2012, Developmental biology.
[53] Qing-You Zhang,et al. Expression pattern and functions of autophagy-related gene atg5 in zebrafish organogenesis , 2011, Autophagy.
[54] S. Kalhan,et al. Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis , 2011, European journal of gastroenterology & hepatology.
[55] E. Feskens,et al. Sharply higher rates of iron deficiency in obese Mexican women and children are predicted by obesity-related inflammation rather than by differences in dietary iron intake. , 2011, The American journal of clinical nutrition.
[56] D. Swinkels,et al. Effect of body mass index reduction on serum hepcidin levels and iron status in obese children , 2010, International Journal of Obesity.
[57] E. Ikonen,et al. Zebrafish: gaining popularity in lipid research. , 2010, The Biochemical journal.
[58] Soo-Ho Choi,et al. Vascular Lipid Accumulation, Lipoprotein Oxidation, and Macrophage Lipid Uptake in Hypercholesterolemic Zebrafish , 2009, Circulation research.
[59] Matthew B Veldman,et al. Zebrafish as a Developmental Model Organism for Pediatric Research , 2008, Pediatric Research.
[60] A. Roach,et al. Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery , 2008, British journal of pharmacology.
[61] I. Mavromichalis,et al. Update on non-alcoholic fatty liver disease in children. , 2007, Clinical nutrition.
[62] K. Widhalm,et al. The association between non‐alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents , 2007, Acta paediatrica.
[63] C. Sirlin,et al. Pediatric Nonalcoholic Fatty Liver Disease: A Critical Appraisal of Current Data and Implications for Future Research , 2006, Journal of pediatric gastroenterology and nutrition.
[64] 乾 あやの,et al. 小児期の nonalcoholic fatty liver disease (NAFLD) , 2006 .
[65] P. Ciampalini,et al. NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice , 2006, Hepatology.
[66] H. Barr,et al. Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus , 2006, British Journal of Cancer.
[67] C. Day. From fat to inflammation. , 2006, Gastroenterology.
[68] G. Li Volti,et al. Antioxidant treatment inhibited glutamate-evoked NF-kappaB activation in primary astroglial cell cultures. , 2005, Neurotoxicology.
[69] J. Halterman,et al. Overweight children and adolescents: a risk group for iron deficiency. , 2004, Pediatrics.
[70] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[71] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[72] C. Day,et al. Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.
[73] M. George. Unmet needs. , 1991, Nursing times.